Establishment Labs (ESTA) Stock Rises in Pre-Market After FDA Grants Approval
The stock value of Establishment Labs Holdings Inc. (NASDAQ: ESTA) has experienced a noteworthy surge subsequent to obtaining regulatory approval from the U.S. Food and Drug Administration (FDA). As of the latest pre-market check, ESTA shares gained 27.35% to $52.46, indicating a strong sign of increased investor confidence over the company’s cutting-edge products. Novel Approval for State-of-the-Art […]
Establishment Labs (ESTA) Stock Rises in Pre-Market After FDA Grants Approval Read More »